Working... Menu

Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus (ClearMEMory)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03527472
Recruitment Status : Recruiting
First Posted : May 17, 2018
Last Update Posted : September 25, 2018
Kleberg Foundation
Information provided by (Responsible Party):
Leslie Crofford, Vanderbilt University Medical Center

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : October 2022
  Estimated Study Completion Date : December 2022